Skip to main content
Menu
  • Meet IdyllaTM
    • IdyllaTM Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
  • IFU(link is external)
  • Secure area
  • Global
  • United States
Open/Close
  • Search
  • Contact us
  • +32 15 632 600
  • Subscribe to news
  • Global
  • United States

IdyllaTM IDH1-2 Mutation Assay Kit - Innovative. Fast. Easy.

HepatoPredict - A prognostic tool to support liver transplantation in patients with hepatocellular carcinoma.

Merlin™ Assay CE-IVD - Helps identify melanoma patients who have a low risk for nodal metastasis.

Study demonstrates IdyllaTM EGFR Mutation Test shortens time to patient management decisions for NSCLC patients

(link is external)

Study shows Rapid IdyllaTM EGFR Testing Alongside NGS Has Potential to Enhance Lung Cancer Patient Health Outcomes.

(link is external)
Oncology Tests van Biocartis

Oncology In Vitro Diagnostic Tests

Biocartis offers IVD tests for colorectal cancer, melanoma and lung cancer

  1. Home
  2. Meet IdyllaTM
  3. Oncology In Vitro Diagnostic Tests
Menu
  • Meet IdyllaTM
    • IdyllaTM Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact

Oncology In vitro diagnostic tests

IdyllaTM EGFR Mutation Test

Fully automated detection of 51 EGFR mutations, directly from 1 FFPE tissue section from patients with mNSCLC.

Lung Cancer
Solid
Read more

IdyllaTM GeneFusion Panel

Fully automated detection of ALK, ROS1 and RET fusions & MET exon 14 skipping, directly from 1 FFPE tissue section from patients with NSCLC.

Lung Cancer
Solid
Read more

IdyllaTM BRAF Mutation Test

Fully automated detection of 7 BRAF mutations, directly from 1 FFPE tissue section from patients with metastatic melanoma.

Melanoma
Solid
Read more

IdyllaTM KRAS Mutation Test

Fully automated detection of 21 KRAS mutations, directly from 1 FFPE tissue section from patients with mCRC.

Colorectal Cancer
Solid
Read more

IdyllaTM NRAS-BRAF Mutation Test

Fully automated detection of 18 NRAS mutations and 5 BRAF mutations, directly from 1 FFPE tissue section from patients with mCRC.

Colorectal Cancer
Solid
Read more

IdyllaTM MSI Test

Fully automated detection 7 monomorphic biomarkers, directly from 1 FFPE tissue section from patients with CRC.

Colorectal Cancer
Solid
Read more
  • Meet IdyllaTM
  • Oncology
  • Oncology Research
  • Partnering
  • Press & Events
  • About Us

Biocartis NV

Generaal De Wittelaan 11B

2800 Mechelen, Belgium

Phone: +32 15 632 600

info@biocartis.com(link sends email)

 

Biocartis US

  • Subscribe to news
  • Contact us
  • Request demo
  • Download center
  • LinkedIn
  • Facebook
  • YouTube
  • Twitter
  • Cookie policy
  • Privacy policy
  • Terms of use
© 2025 Biocartis Created by O2 Agency(link is external)